Results 211 to 220 of about 326,926 (265)

Interferon therapy for chronic hepatitis B in children: an immunological perspective. [PDF]

Front Immunol
Zhao Y, Wang Y, Yu G.
europepmc   +1 more source

Does Hepatosteatosis Affect Shear-Wave Elastography Values in Chronic Hepatitis Patients with the Same Histological Fibrosis Grade? [PDF]

Diagnostics (Basel)
Karatay E, Eren A.
europepmc   +1 more source

Validation of a Point-Of-Care Ultrasound for Hepatitis Among Front-Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia. [PDF]

J Viral Hepat
Bertoni C, Kanunga A, Sinkala E, Syabbalo E, Chitundu H, Chikwezi A, Chibundi C, Muula GK, Bosomprah S, Capra N, Lolatto R, Morsica G, Castagna A, Wallrauch C, Heller T, Vinikoor MJ.   +15 more
europepmc   +1 more source

Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B. [PDF]

Infect Dis Ther
Cesanelli F, Nozza O, Gottardi F, Mosti F, Zaltron S, Tiecco G, Scarvaglieri I, Spinetti A, Castelli F, Quiros-Roldan E.   +9 more
europepmc   +1 more source

Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B. [PDF]

World J Virol
Huang XF, Zeng JQ.
europepmc   +1 more source

HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Li J, Hu Z, Wu M, Ji Y, Zhang X, Chen F, Wu X, Zhang Q, Chen C, Zhu C, Zhu L.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic hepatic porphyria in chronic aggressive hepatitis

Klinische Wochenschrift, 1971
An acquired (“symptomatic”) chronic hepatic porphyria (CHP) is described, which develops secondarily following damage to the liver tissue and is characterized by the absence of clinical symptoms. It can be differentiated biochemically from latent porphyria cutanea tarda (PCT) by a lower total porphyrin excretion (0.18–0.64 mg/l) and a relatively ...
M, Doss, D, Look, H, Henning
openaire   +2 more sources

TREATMENT OF CHRONIC HEPATITIS

Gastroenterology Clinics of North America, 1992
Chronic hepatitis is an etiologically diverse syndrome. The approach to treatment depends on the cause of the disease. The efficacy of immunosuppressive treatment of chronic autoimmune hepatitis has long been established, and most patients with this disease can be treated successfully with prednisone and azathioprine.
L, Lambiase, G L, Davis
openaire   +2 more sources